Company Category: Life Sciences

00930277

AB DigiHealth Inc.

AB DigiHealth Inc. stands as a pioneering, modern core laboratory dedicated to advancing genomic research. Originating as a startup from Center for Genomic Medicine, National Cheng Kung University in Taiwan, our mission is to bridge the gap between scientific discoveries and clinical applications, providing a comprehensive solution for maternal-fetal precision medicine to the world. Harnessing state-of-the-art Next-Generation Sequencing (NGS) technology, advanced bioinformatics, and AI predictive algorithms, our goal is to usher prenatal genetic testing into a new era. As guardians of maternal-fetal health, we endeavor to create an efficient, empowering digital solution that leverages cloud-based NGS analytics pipelines and AI-based companion diagnosis. Our vision is to establish a next-generation healthcare system characterized by high accuracy, enhancing operational efficiency in laboratories and clinics.

Read More
00907592

4DMedical

4DMedical is a global leader in innovative respiratory and cardiopulmonary imaging software. Our SaaS solutions deliver non-invasive, regional, and lobar quantitative lung function analysis—giving pulmonologists and clinicians the power to act sooner and with objective data for patients with unexplained dyspnea, asthma, COPD, and other lung diseases. We also support early intervention with low-dose lung health screenings and physician-customized smoking cessation tools to help prevent disease progression. 4DMedical’s CT:VQ™ is the world’s first and only non-contrast post-processing technology that transforms routine chest CT scans into detailed, quantitative maps of lung ventilation (V) and perfusion (Q), all without injected contrast or radioisotopes. CT:VQ™ seamlessly fits into your existing workflow, delivering results directly for rapid interpretation—all from the CT you already order. You can act sooner with objective perfusion data—from the CT you already order. Enhance patient care with actionable functional data from every chest CT—accelerating your path from suspicion to confident clinical decision. | 4DMedical is a global leader in innovative respiratory and cardiopulmonary imaging software. Using advanced, non-invasive CT imaging technology, our SaaS offerings provide non-invasive, regional and lobar quantitative lung function analysis for unparalleled insights into cardiopulmonary health. With a single CT lung scan, 4DMedical provides automated, quantitative analysis that equips radiologists with detailed insights to support ordering physicians in delivering optimal patient care. Now available: CT:VQ™ is the world’s first and only non-contrast post-processing technology that transforms routine chest CT scans into quantitative, lobar ventilation (V) and perfusion (Q) maps—without contrast media, inhaled agents, or added scan time. Results are automatically delivered to PACS, ready for radiologist interpretation alongside the source CT images. For Radiologists: – One modality, one department: Complete pulmonary imaging with no new hardware or workflow steps – Add objective, functional metrics to every routine CT – Improve reporting consistency and inter-reader reproducibility – Automated, quantitative reporting and seamless PACS integration – Peer-reviewed, proven correlation with spirometry and radiologist-based metrics – Enhance your CT utility—structure and function, together in a single exam With 4DMedical, radiologists can deliver both structural and functional lung, and cardiac assessment from standard CT, enhancing diagnostic confidence, improving report value, and streamlining workflow efficiency.

Read More
100292

3DHISTECH

DHISTECH’s Pannoramic Pathology System is a complex package of instruments and software supported by one vendor. It covers each stage of the pathology workflow in research and diagnostics, by providing solutions to the complete digitization process of histology, cytology and hematology samples and case management through its functions and features.

Read More
3859226

2D Tubes by AutoGen

2D Tubes by AutoGen is now a North American Distributor of LVL Technologies LVL Technologies has been synonymous with outstanding quality and innovation in sample storage, sample archiving, and liquid handling since 1986, and we are pleased to now offer a wide range of innovative sample storage solutions. Specializing in liquid handling and sample storage, the SAFE® line provides secure, efficient, ecological, and modern solutions for your laboratory. With 2D-coded tubes and space-saving SBS racks, SAFE® ensures reliable sample storage at extremely low temperatures down to -196°C (LN2). These products support error-free and automated sample processing and provide a technical infrastructure with scanners and cappers/decappers designed for the highest precision. Why 2D-Coded? 2D Tubes by AutoGen only offers 2D-coded tubes. 2D tubes are permanently laser-etched and include a 2D code on the base. Additionally, a 1D (linear barcode) and a Human-Readable Number are on the side, providing unmatched sample audit traceability, enabling sample tracking and data sharing across multiple users, labs, locations, and automation capabilities. | A Tube Is Not Just A Tube Say hello to a more efficient, accurate, and sustainable lab workflow! 2D Tubes by AutoGen is excited to announce our new partnership with LVL Technologies GmbH, bringing cutting-edge 2D Tubes and accessories straight to your lab. Here’s what’s waiting for you in our updated portfolio: • Third Generation SAFE® 2D Tubes • Secure Storage: SAFE® 2D Tubes ensure the safety and integrity of your samples. They don’t leak and they don’t leach! • Automation Ready: Our products are ideal for automated laboratory processes. • Space-Saving Design: The SBS racks enable efficient and space-saving storage. • Temperature Resistant: Suitable for storage at low temperatures down to -196°C. It all starts with the tube. This is where your valuable samples, which you’ve meticulously obtained and preserved, are stored. But to truly work efficiently with 2D Tubes, the right accessories are indispensable. These tools ensure smooth and effective workflows, making your hard-earned samples easier to manage and safeguard. High-Speed Decappers & 2D Readers – from Single Channel to 96 Well Format • Decap or scan 96 tubes in under 40 seconds. • Full integration with all liquid handlers and flexible LIMS compatibility. Laser Marker (TLM 864) • Replace paper labels with durable laser-etched markings. • Customize logos and labels, processing up to 500 tubes per hour. Say goodbye to inefficiencies and hello to precision and scalability! Come visit us at Booth #256 to learn more about the future of lab technology or explore the product portfolio here.

Read More
3859020

1Cell.Ai

1Cell.Ai, based in Foster City, California, is at the forefront of precision oncology, driving personalized cancer therapy with its innovative multi-omics technologies. Among its key advancements is the breakthrough single cell multi-omics platform, which allows for the comprehensive analysis of individual cancer cells across multiple molecular levels, including genomics, transcriptomics, proteomics, and epigenomics. This technology provides deep insights into tumor heterogeneity, enabling the identification of rare cell populations that may drive metastasis or resistance to therapy, and tailoring treatments to improve patient outcomes. 1Cell.Ai has actively contributed to the scientific community, with numerous publications and presentations at leading oncology conferences such as the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). Their research highlights include the application of AI-enabled technologies in predicting homologous recombination deficiency (HRD) from histopathology images and the use of Circulating Tumor Cells (CTCs) for non-invasive cancer monitoring. These studies, presented in journals like the Journal of Clinical Oncology, underscore the potential of combining advanced diagnostics with artificial intelligence to enhance cancer care. The company’s integrated platforms—OncoIncytes® for multiomic profiling, 1Cell SOLO® for AI-driven single-cell isolation, and iCore™ for data integration—are purpose-built to advance: Antibody-drug conjugate (ADC) development, Translational biomarker programs and Patient stratification in clinical trials. See how 1Cell.Ai can democratize precision cancer monitoring and testing to make cancer testing actionable, accessible, and affordable. Operating from their state-of-the-art laboratory in Foster City, California, 1Cell.Ai adheres to the highest standards of quality, ensuring that their tests provide clinicians with the most reliable and comprehensive data to guide treatment decisions. Through strategic partnerships with academic institutions and industry leaders, 1Cell.Ai continues to push the boundaries of cancer care. Their single cell multi-omics technology, in particular, has been recognized for its potential to revolutionize Next-Gen Translational Research marking a significant advancement in the field of personalized oncology.​

Read More
148868

10ZiG Technology

10ZiG delivers secure, standardized, and centrally managed endpoints for healthcare organizations. Our Imprivata Ready thin clients, zero clients, and PC repurposing software enable safe access to clinical systems across VDI, DaaS, and cloud environments by reducing PHI exposure and supporting HIPAA-aligned security. 10ZiG helps healthcare leaders improve clinician experience while lowering TCO, risk, and operational complexity.

Read More